Chinese vaccine Sinopharm gets emergency approval by WHO
1 minute read
Geneva, May 7 (EFE).- The World Health Organisation approved emergency use of the Covid-19 vaccine made by Chinese company Sinopharm on Friday.
The approval means Sinopharm can be rolled out globally, a WHO statement said.
“The addition of this vaccine has the potential to rapidly accelerate Covid-19 vaccine access for countries seeking to protect health workers and populations at risk,” said Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products.
Sinopharm has been shown to be up to 79% effective in preventing severe cases of Covid and the symptoms associated with this disease, the chairman of an advisory WHO panel, Alejandro Cravioto, said at a press conference.